Literature DB >> 21283022

Hydrogen sulfide: a novel signaling molecule in the vascular system.

Yi-Hong Liu1, Chang-Dong Yan, Jin-Song Bian.   

Abstract

Hydrogen sulfide (H2S) is an endogenous gasotransmitter produced in mammalian cells. It is responsible for physiological functions in many organs and systems, with attention focused mainly on the cardiovascular and nervous systems. In the vascular system, H2S produces biphasic effects in regulation of vascular tone. At lower concentrations, it induces vasoconstriction predominantly via decreasing cyclic adenosine monophosphate in smooth muscle cell and inhibiting the production and bioavailability of nitric oxide. At higher concentrations, it produces vasorelaxation mainly through opening of KATP channels and induction of intracellular acidification. Scavenging reactive oxygen species and elevation of cyclic guanosine monophosphate are also implicated in the vasorelaxant response. This review presents an overview of the current knowledge of H2S in the vascular system, with special emphasis and discussion on the involvement of various signaling pathways and ion channels based on current understanding and reported literature till date.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21283022     DOI: 10.1097/FJC.0b013e31820eb7a1

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  21 in total

1.  Hydrogen sulfide treatment reduces blood pressure and oxidative stress in angiotensin II-induced hypertensive mice.

Authors:  Mohammad R Al-Magableh; Barbara K Kemp-Harper; Joanne L Hart
Journal:  Hypertens Res       Date:  2014-08-07       Impact factor: 3.872

2.  H(2)S inhibits oscillatory shear stress-induced monocyte binding to endothelial cells via nitric oxide production.

Authors:  Young-Mi Go; Hye-Rim Lee; Heonyong Park
Journal:  Mol Cells       Date:  2012-10-30       Impact factor: 5.034

3.  Beneficial effects of diminished production of hydrogen sulfide or carbon monoxide on hypertension and renal injury induced by NO withdrawal.

Authors:  Sebastiaan Wesseling; Joost O Fledderus; Marianne C Verhaar; Jaap A Joles
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

Review 4.  Regulation of vascular tone homeostasis by NO and H2S: Implications in hypertension.

Authors:  Sevda Gheibi; Sajad Jeddi; Khosrow Kashfi; Asghar Ghasemi
Journal:  Biochem Pharmacol       Date:  2018-01-09       Impact factor: 5.858

Review 5.  Regulation of carbohydrate metabolism by nitric oxide and hydrogen sulfide: Implications in diabetes.

Authors:  Sevda Gheibi; Alan P Samsonov; Shahsanam Gheibi; Alexandra B Vazquez; Khosrow Kashfi
Journal:  Biochem Pharmacol       Date:  2020-01-21       Impact factor: 5.858

Review 6.  Emerging role of hydrogen sulfide in hypertension and related cardiovascular diseases.

Authors:  Guoliang Meng; Yan Ma; Liping Xie; Albert Ferro; Yong Ji
Journal:  Br J Pharmacol       Date:  2014-11-24       Impact factor: 8.739

7.  Hydrogen sulfide alleviates myocardial collagen remodeling in association with inhibition of TGF-β/Smad signaling pathway in spontaneously hypertensive rats.

Authors:  Lili Sun; Hongfang Jin; Lujing Sun; Siyao Chen; Yaqian Huang; Jia Liu; Zhenzhen Li; Manman Zhao; Yan Sun; Chaoshu Tang; Bin Zhao; Junbao Du
Journal:  Mol Med       Date:  2015-01-20       Impact factor: 6.354

8.  Hydrogen sulfide suppresses the expression of MMP-8, MMP-13, and TIMP-1 in left ventricles of rats with cardiac volume overload.

Authors:  Chao-Ying Zhang; Xiao-Hui Li; Ting Zhang; Jin Fu; Xiao-Dai Cui
Journal:  Acta Pharmacol Sin       Date:  2013-08-26       Impact factor: 6.150

Review 9.  Hydrogen sulfide: physiological properties and therapeutic potential in ischaemia.

Authors:  Eelke M Bos; Harry van Goor; Jaap A Joles; Matthew Whiteman; Henri G D Leuvenink
Journal:  Br J Pharmacol       Date:  2015-03       Impact factor: 8.739

10.  Bronchodilatory effect of hydrogen sulfide in rat.

Authors:  Mohammad Kazem Gharib-Naseri; Shadan Saberi; Seyyed Ali Mard; Seyyed Mahmood Latifi
Journal:  Iran J Basic Med Sci       Date:  2012-07       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.